A hidden clue may explain why some mutated cells become cancerous and others don’t: how fast they divide. A new study from ...

USC researchers have developed an innovative type of cancer-fighting immune cell, the EchoBack CAR T-cell, that uses focused ...

called adaptive NK cells, to remember ovarian tumors and effectively attack them. The discovery, published in Cancer Immunology Research, could pave the way for new, more powerful immunotherapies for ...

A team of researchers led by Dr. Rod Bremner at the Lunenfeld-Tanenbaum Research Institute, Sinai Health in Toronto, has made a significant breakthrough in understanding cancer susceptibility. Their ...

Adoptive Cell Transfer (ACT) includes a class of immunotherapy approaches to treat cancer.  This procedure focuses on a ...

Cancer starts when cells acquire genetic mutations that prompt them to proliferate out of control, forming tumors. Not all cells that carry such mutations will turn into cancer, however.

Explore GISTs, rare GI tumors. Discover key details on genetic causes, diagnostic methods, and cutting-edge treatment ...

In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors, such as ...